| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |